Form 4 for PCVX Vaxcyte, Inc.
Accepted 2026-08-05 16:59:11 ET · period of report 2026-08-03 · accession 0001813798-26-000015 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-08-05 16:59 | 2026-08-03 | PCVX | Wassil Jim | COO | M - OptEx | $5.35 | +2,250 | 159.8K | +1% | +$12.0K |
| DMT | 2026-08-05 16:59 | 2026-08-03 | PCVX | Wassil Jim | COO | S - Sale+OE | $53.86 | -2,250 | 157.5K | -1% | -$121.2K |
| DT | 2026-08-05 16:59 | 2026-08-03 | PCVX | Wassil Jim | COO | M - OptEx | $0.00 | -2,250 | 68.9K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-03 | M | A | 2,250 | $5.35 | 159,791 | D | — | — | (F1) Includes 781 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026. |
| 2 | Common | Common Stock | 2026-08-03 | S | D | 861 | $53.50 | 158,930 | D | — | — | (F2) The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025. (F3) The price reported is a weighted-average price. The shares were sold at prices ranging from $52.915 to $53.91. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2026-08-03 | S | D | 1,389 | $54.09 | 157,541 | D | — | — | (F2) The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025. (F4) The price reported is a weighted-average price. The shares were sold at prices ranging from $53.935 to $54.36. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 4 | Derivative | Stock Option (right to buy) | 2026-08-03 | M | D | 2,250 | $0.00 | 68,898 | D | $5.35 · — to 2030-04-17 | 2,250 Common Stock | (F5) Stock Option is fully vested and exercisable. |